IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid Tumors May 22, 2023
Nurosene Appoints NetraMark Co-Founder Dr. Joseph Geraci PhD as Chief Scientific Officer October 18, 2021